CFDE Data Portal | Search CAP2P1

	Label	Description
	CAP2P1 associations Collection (Entity type)	Associations for CAP2P1_associations
	CAP2P1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	CAP2P1 Gene (Entity type)	ENSG00000259151 - cyclase associated actin cytoskeleton regulatory protein 2 pseudogene 1
	GSE206931 WDR5 inhibition WIN 3 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE115395 enzalutamide LNCaP 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE172494 nicotinamide 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	ASIC4 IDG ionchannel ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GTEx Vagina 20-29 vs 30-39 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Pancreas 20-29 vs 50-59 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Thyroid 20-29 vs 60-69 Up Gene Set (Entity type)	A Gene Set from GTEx

CAP2P1 associations

Associations for CAP2P1_associations

CAP2P1 associations.tsv

A file from IDG as part of the Harmonizome project

CAP2P1

ENSG00000259151 - cyclase associated actin cytoskeleton regulatory protein 2 pseudogene 1

GSE206931 WDR5 inhibition WIN 3 v 6 human up

A Gene Set from LINCS

GSE115395 enzalutamide LNCaP 2 v 5 human up

A Gene Set from LINCS

GSE172494 nicotinamide 3 v 1 human dn

A Gene Set from LINCS

ASIC4 IDG ionchannel ARCHS4 coexpression

A Gene Set from IDG

GTEx Vagina 20-29 vs 30-39 Down

A Gene Set from GTEx

GTEx Pancreas 20-29 vs 50-59 Up

A Gene Set from GTEx

GTEx Thyroid 20-29 vs 60-69 Up

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.